Close Menu

NEW YORK (GenomeWeb News) — Stem cell therapeutics and research tools firm StemCells said today that it has transferred the Melbourne, Australia-based operations of recently acquired Stem Cell Sciences to StemCells' facilities in Cambridge, UK, and Palo Alto, Calif.

The move is part of StemCells' efforts to streamline operations following its estimated $4.8 million acquisition of SCS, which it originally announced in March and closed on April 1.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.